Table 1.
Ceftobiprole and ceftaroline breakpoints and ECOFF values of bacterial species and groups, according to EUCAST-2019.
Microorganism | Ceftobiprole | Ceftaroline | ||||
---|---|---|---|---|---|---|
Clinical breakpoints (mg/L) | ECOFF (mg/L) | Clinical breakpoints (mg/l) | ECOFF (mg/L) | |||
Susceptible (≤) | Resistant (>) | Susceptible (≤) | Resistant (>) | |||
S. aureus(including MRSA) | 2 | 2 | 1 | 1* | 1** 2*** |
0.5 |
S. pneumoniae(including PNSa) | 0.5 | 0.5 | 0.03 | 0.25 | 0.25 | 0.03 |
E. faecalis | -b | - | NDc | - | - | ND |
Enterobacterales | 0.25 | 0.25 | 0.12-0.25 | 0.5 | 0.5 | 0.12-0.25 |
P. aeruginosa | IEd | IE | 8 | - | - | ND |
H. influenzae | IE | IE | 0.25 | 0.03 | 0.03 | 0.03 |
M. catarrhalis | IE | IE | ND | IE | IE | ND |
Non-species relatede | 4f | 4 | - | 0.5 | 0.5 | - |
Including pneumonia
Pneumonia isolates
Other isolates than pneumonia
Penicillin-non-susceptible
-: no breakpoint
ND: not determined;
IE: insufficient evidence
PK-PD breakpoints
Based on PK-PD target for Gram-negative organisms.